PCSK9抑制剂Evolocumab和Alirocumab降低血脂和减少心血管事件的有效性和安全性评价
摘要：
1文献来源研究一:Sabatine MS,Giugliano RP,Wiviott SD,et al.Efficacy and safety of Evolocumab inreducing lipids and cardiovascular events[J].N EnglJ Med,2015,372(16):1500-1509.研究二:Robinson JG,Farnier M,Krempf M,
会员登录
